Insider buying
~$113K100K sh @ $1.13
Traded May 21, 2025 · filed 1 day later
Prime Medicine's Chief Technical Officer paid $113K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 7, 2025
2 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 7, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q4 2024 13F
5,150,233
3,095,172
−39.9%
Share count drives classification; reported value also moves with price
0.06%
Within the filing's reported positions, not the manager's total assets
2
For Q1 2025
Insider buying
Traded May 21, 2025 · filed 1 day later
Prime Medicine's Chief Technical Officer paid $113K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded May 20, 2025 · filed 2 days later
Prime Medicine's Chief Business Officer paid $24K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Insider buying
Traded May 21, 2025 · filed 1 day later
The CEO of Prime Medicine paid $147K out of pocket for Prime Medicine shares. 3 other people at Prime Medicine bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.